Document is current
Any future updates will be listed below
-
Authors
Reeve, Mary Pat https://orcid.org/0000-0003-1788-2321
Loomis, Stephanie
Nissilä, Eija
Soare, Thomas W. https://orcid.org/0000-0002-4903-8646
Rausch, Tobias https://orcid.org/0000-0001-5773-5620
Zheng, Zhili https://orcid.org/0000-0003-2102-221X
DELLA BRIOTTA PAROLO, Pietro
Ben-Isvy, Daniel https://orcid.org/0000-0002-1596-983X
Aho, Elias
Cesetti, Emilia https://orcid.org/0009-0000-9546-8623
Okunuki, Yoko
McLaughlin, Helen
Mäkelä, Johanna
,
Kurki, Mitja
Talkowski, Michael E. https://orcid.org/0000-0003-2889-0992
Korbel, Jan O. https://orcid.org/0000-0002-2798-3794
Connor, Kip
Meri, Seppo
Daly, Mark J. https://orcid.org/0000-0002-0949-8752
Runz, Heiko https://orcid.org/0000-0002-2133-7345
- License Information
-
More Information
Article History
Received: 11 November 2024
Accepted: 16 June 2025
First Online: 1 July 2025
Competing interests
: S.L., Y.O., H.M.L., K.C., and H.R. were employees at Biogen during data generation for this study. S.L. is an employee of Bristol-Myers Squibb. Y.O. and K.C. are employees of Johnson & Johnson. H.M.L. is an employee of Moderna. J.M. is an employee of FinBB. M.D. is a co-founder of Maze Therapeutics. TS and HR are employees at insitro Inc. The remaining authors declare no competing interests.
